Humasis ranked among the top searched stocks on 4 days within the past month.


As of 2:31 PM on the 24th, Humasis is trading at 12,850 KRW, down 5.86% from the previous day. This represents a 17.36% decline compared to September 11. Humasis is known as an in vitro diagnostic device company.

Over the past 5 days, individual investors have net purchased 11,475 shares, while foreigners and institutions have net purchased 3,756 shares and 679 shares, respectively.


On September 23, Humasis was a market topic as it "closed up over 3% on news of export approval for rapid diagnostic kits."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing